non-small cell lung cancer Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug The companies will jointly develop and commercialize Guardant360 CDx and Guardant360 TissueNext for taletrectinib treatment in advanced and metastatic NSCLC. Thermo Fisher Scientific, AstraZeneca to Develop Solid Tissue and Blood-Based CDx Test The firms will develop the NGS-based CDx for non-small cell lung cancer drug Tagrisso using the Oncomine Dx Express Test on the Genexus Dx System. Quest Diagnostics to Offer Agilent Companion Test for Mirati Therapeutics NSCLC Treatment Agilent's companion diagnostic for Mirati's non-small cell lung cancer treatment Krazati will be available through Quest's national healthcare network. FDA Approves Foundation Medicine Blood Test as CDx for Rozlytrek FoundationOne Liquid CDx, a liquid biopsy test, is the only blood-based CDx approved for the targeted cancer therapy. Japanese Lung Cancer Genomic Screening Project Expands in Asia-Pacific LC-SCRUM-Asia, a genomic screening project and database that initially launched in Japan in 2013, is expanding and will cover additional countries in the Asia-Pacific region. Dec 14, 2022 Functional Precision Medicine Firm Kiyatec Raises $18M in Series C Funding Round Nov 28, 2022 Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment Oct 26, 2022 Hedera Dx Hopes to Hasten Liquid Biopsy Adoption in Europe With Streamlined Platform Premium Sep 28, 2022 Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders Premium Sep 16, 2022 Non-Small Cell Lung Cancer Risk Variants Profiled in Han Chinese Population Aug 30, 2022 Thermo Fisher Scientific Obtains CE-IVD Mark for Targeted NGS Oncology Test, Analysis Software Aug 29, 2022 Combination of Genomic, Other Factors Improves Treatment Response Prediction in Lung Cancer Aug 12, 2022 Guardant Health, Thermo Fisher Scientific Tests Approved as CDx to Enhertu in Lung Cancer Jun 22, 2022 Biocartis, AstraZeneca Ink Companion Diagnostic Pact Jun 15, 2022 Blood-Based PD-L1 Tracking Could Offer Improved Response Prediction for Lung Cancer Immunotherapy Premium Jun 9, 2022 Sophia Genetics, GE Healthcare Begin DEEP-Lung-IV Data Collection, Technology Integration Premium Jun 9, 2022 Tempus, Lilly Ink Partnership to Offer No-Cost NGS for Advanced NSCLC Patients Jun 9, 2022 FDA Approves Foundation Medicine Test as CDx With Roche's Rozlytrek Jun 3, 2022 Foundation Medicine to Provide Comprehensive Genomic Profiling Tests in Lung Cancer Screening Trial Apr 7, 2022 Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study Premium Feb 16, 2022 Invitae Garners CE-IVD Mark for Two Comprehensive Genomic Profiling Tests Feb 10, 2022 Genetron Health, Hutchmed Partner to Develop CDx for Lung Cancer Tyrosine Kinase Inhibitor Feb 2, 2022 Blood Lipid Mass Spectrometry Assay May Enable Early-Stage Lung Cancer Detection Dec 13, 2021 OncoHost, Heidelberg University Hospital Strike Lung Cancer Biomarker Alliance Dec 9, 2021 FDA Approves Thermo Fisher Scientific Oncomine Dx Assay as CDx for Janssen Lung Cancer Drug Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.